Monitor for any future 13D conversion by CRGI or other large holders, though the passive certification makes this unlikely. The combined disclosed passive ownership (CRGI 5.4% + GIC 8.49%) exceeds 13%, which could become relevant in any future control contest.
Price Chart
How similar events traded
Executive Summary
Capital Research Global Investors filed a Schedule 13G disclosing a 5.4% passive stake in Medline Inc., representing 47,768,233 shares as of September 30, 2026. This is a new 5%+ disclosure by a major institutional investor, adding to the existing passive ownership by GIC (8.49% as of November 4). The filing confirms passive intent with no control-related purpose.
Key Financial Metrics
Key Facts
- Capital Research Global Investors filed a new Schedule 13G disclosing beneficial ownership of 47,768,233 shares of Medline Inc.
- The stake represents 5.4% of the 877,351,218 shares outstanding as of September 30, 2026.
- The filing certifies passive investment intent under Rule 13d-1(b), with no purpose of changing or influencing control.
- This is a new 5%+ disclosure; no prior 13G or 13D by this filer was found in the provided context.
- GIC Private Ltd previously disclosed an 8.49% passive stake on November 4, 2026, down from 13.03% on October 30.
Financial Impact
Stake valued at approximately $3.0B based on $55.5B market cap and 5.4% ownership.
Risk Factors
- No material risks identified from this passive stake filing.
- Document contains text addressed to automated readers (XML tags, EDGAR headers).
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001422848-26-000138 |
| Document: 0001422848-26-000138-index.html | 0001422848-26-000138 |
| Document: 0001422848-26-000138.txt | 0001422848-26-000138 |
Track record
30 reports on MDLN
5 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 5 of 8 went positive at some point.
Filters
- Nov 16, 2026today Press Release Bearish 5/10 Entry $36.40 Now $39.17 −7.61% settles Nov 23
- Nov 16, 2026today S-1 Neutral 4/10 Entry $39.05 Now $39.17 +0.31% settles Nov 23
- Nov 13, 20263d ago SC 13G Neutral 3/10 Viewing Entry $42.00 Now $39.17 −6.74% settles Nov 23
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $40.71 to $39.17 Now $39.17 −3.78% ▼ −3.78% −2.09% vs SPY
- Nov 4, 202612d ago 8-K Neutral 5/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $40.35 to $42.16 Now $39.17 −2.92% ▲ +4.49% +5.40% vs SPY
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $34.09 to $40.91 Now $39.17 −14.90% ▼ −20.01% −20.59% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $32.12 to $39.64 Now $39.17 +21.95% ▲ +23.41% +26.12% vs SPY
- Oct 21, 202626d ago 8-K Bearish 6/10 Entry $34.88 to $32.00 Now $39.17 −12.30% ▲ +8.26% +8.96% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers